A comprehensive overview and safety evaluation of fremanezumab as a preventive therapy for migraine.
Saved in:
| Title: | A comprehensive overview and safety evaluation of fremanezumab as a preventive therapy for migraine. |
|---|---|
| Authors: | Parikh SK; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Burkett JG; Allegheny Health Network Headache Center, Pittsburgh, PA, USA., Silberstein SD; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. |
| Source: | Expert opinion on drug safety [Expert Opin Drug Saf] 2020 May; Vol. 19 (5), pp. 537-543. Date of Electronic Publication: 2020 Mar 09. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32116061 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A comprehensive overview and safety evaluation of fremanezumab as a preventive therapy for migraine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Parikh+SK%22">Parikh SK</searchLink>; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Burkett+JG%22">Burkett JG</searchLink>; Allegheny Health Network Headache Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Silberstein+SD%22">Silberstein SD</searchLink>; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101163027%22">Expert opinion on drug safety</searchLink> [Expert Opin Drug Saf] 2020 May; Vol. 19 (5), pp. 537-543. <i>Date of Electronic Publication: </i>2020 Mar 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101163027 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-764X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214740338%22">14740338 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Drug Saf <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32116061 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/14740338.2020.1737673 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 537 Titles: – TitleFull: A comprehensive overview and safety evaluation of fremanezumab as a preventive therapy for migraine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Parikh SK – PersonEntity: Name: NameFull: Burkett JG – PersonEntity: Name: NameFull: Silberstein SD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2020 May Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1744-764X Numbering: – Type: volume Value: 19 – Type: issue Value: 5 Titles: – TitleFull: Expert opinion on drug safety Type: main |
| ResultId | 1 |